Products

Human NAT1(N-Acetyltransferase 1) ELISA Kit
ELK4142
Size： Price：
48 T $320.00
96 T $458.00
Manual MSDS Send email to us

Overview

Product name: Human NAT1(N-Acetyltransferase 1) ELISA Kit
Reactivity: Human
Alternative Names: AAC1; Arylamine N-Acetyltransferase; Arylamide acetylase 1; Monomorphic arylamine N-acetyltransferase
Assay Type: Sandwich
Sensitivity: 0.61 ng/mL
Standard: 100 ng/mL
Detection Range: 1.57-100 ng/mL
Sample Type: Serum, plasma, tissue homogenates and other biological fluids.
Assay Length: 3.5h
Research Area: Enzyme & Kinase;
Uniprot ID: P18440
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NAT1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human NAT1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human NAT1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human NAT1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (ng/mL) OD Corrected OD
100.00 2.291 2.222
50.00 1.528 1.459
25.00 1.175 1.106
12.50 0.933 0.864
6.25 0.509 0.440
3.13 0.347 0.278
1.57 0.235 0.166
0.00 0.069 0.000

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant NAT1 and the recovery rates were calculated by comparing the measured value to the expected amount of NAT1 in samples.
Matrix Recovery range Average
serum(n=5) 82-95% 88%
EDTA plasma(n=5) 94-105% 98%
Heparin plasma(n=5) 94-107% 100%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NAT1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 89-97% 85-92% 95-103% 87-93%
EDTA plasma(n=5) 89-102% 97-103% 88-96% 95-101%
Heparin plasma(n=5) 95-102% 85-96% 90-98% 82-93%